Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 7070939Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Pharmacology
NIH Funding · FY2026
Linked Award Amount
$2.8M
Full award amounts, FY2026
Award Records
4
Records listing this PI
Award-Linked Rank
#1,719
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Lingjun Li as a PI. Multi-PI records show the full award amount for context.
- 1S10OD036327-01A1S10Acquisition of a Highly Sensitive Time of Flight (ToF) Mass Spectrometry System with Novel Fragmentation Capabilities for Qualitative and Quantitative Analysis$1Maward amount
- 5R01AG078794-05R01Creating a region- specific biomolecular atlas of the brain of Alzheimer’s disease$740Kaward amount
- 5R01AG052324-05R01DiLeu-enabled multiplexed quantitation for biomarker discovery and validation in Alzheimer’s disease$567.1Kaward amount
- 5R01DK071801-19R01Mass Spectrometric Studies of Neuropeptides in Feeding$431.6Kaward amount
Award organization
Organizations that administered FY2026 awards listing Lingjun Li as a PI.
FY2026 award administered by University of Wisconsin-Madison (WI).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of Wisconsin-Madison
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #5484
- 2025$2M Cumulative Funding
- 2025R01 Grant Holder
- 2026$5M Cumulative Funding
- 2026Entered Top 25% NationallyRanked #1719
- 2026Entered Top 10% NationallyRanked #1719
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Lingjun Li.